Brokers & Partners

COVID-19 Vaccine Information

Now that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization for two COVID-19 vaccines—Pfizer/BioNTech and Modernayour employer groups are likely wondering what’s next?

We know initial supplies of the vaccines will be limited. Most states will have a phased approach to distribution, with highest-risk populations like healthcare workers and nursing home residents targeted first. As larger quantities of the vaccines become available in the coming weeks and months, each state will communicate how and where the vaccines are available and when you can receive one.

CareFirst members will pay $0 for any authorized vaccine when it is made available to the public, regardless of manufacturer.

Initially, the federal government will purchase and distribute all COVID-19 vaccinations. During this period, employer-sponsored plans will only be responsible for the administration costs rather than the entire cost of the vaccines.

Administration costs are based on the Centers for Medicare and Medicaid Services rates and are estimated to be about $17 for the first dose and $28 for the second, for a total cost of approximately $45. As additional vaccines are authorized and become available, different rates may be determined.

As more information becomes available, we will update this page. Here are some additional resources:

Frequently asked Questions

Expand All | Collapse All

CareFirst members will pay $0 for any authorized vaccine that is made available to the public, regardless of manufacturer (e.g., Pfizer, Moderna and those yet to be authorized).

No. Currently, the federal government is purchasing all supplies of the vaccine and distributing them to state and local health departments.

On-site vaccination might be possible in late 2021 if vaccine supplies are adequate.

State governments will likely prioritize distribution to people with the highest risk for COVID-19 disease and complications, like healthcare workers and nursing home residents, followed by teachers and childcare workers and those with underlying conditions.

No, this would violate ERISA. However, it’s possible that the government will issue guidance addressing this concern.

Employers should seek advice from their legal counsel before issuing any vaccine mandate. Employers may want to consider waiting for the vaccine’s full approval from the FDA as well as ensuring there are adequate supplies.

The COVID-19 vaccine will protect the person receiving it from getting the disease. However, to protect those who are not yet vaccinated, it will be important to continue:

  • Wearing a mask
  • Practicing social distancing
  • Washing your hands

Expand All | Collapse All